ReviewCritical care (London, England)2005
Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.
Review in Critical care (London, England), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 42 citations in OpenAlex.
- Acute Respiratory Failure in Autoimmune Rheumatic Diseases: A Review.Journal of clinical medicine · 2024Review
- Causes of acute respiratory failure in patients with small-vessel vasculitis admitted to intensive care units: a multicenter retrospective study.Annals of intensive care · 2021Article
- Cyclophosphamide for interstitial lung disease-associated acute respiratory failure: mortality, clinical response and radiological characteristics.BMC pulmonary medicine · 2021Article
- Predictors of Mortality in Critically Ill Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Frontiers in medicine · 2021Article
- Main tract stenosis complicated by granulomatous with polyangiitis: A case report.Experimental and therapeutic medicine · 2020Article
- Pituitary dysfunction in granulomatosis with polyangiitis.Clinical rheumatology · 2020Review
- Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study.Critical care (London, England) · 2016Article
- Role of gingival manifestation in diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis).Journal of periodontal & implant science · 2015Article
- Pulmonary-renal syndromes: Experience from an Indian Intensive Care Unit.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2015Article
- Prognosis and ICU outcome of systemic vasculitis.BMC anesthesiology · 2013Article
- Outcome of patients with connective tissue disease requiring intensive care for respiratory failure.Rheumatology international · 2012Article
- Wegener's granulomatosis in a middle-aged woman presenting with dyspnea, rash, hemoptysis and recurrent eye complaints: a case report.Journal of medical case reports · 2012Article
- [Dermatological conditions requiring intensive care].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2012Review
- Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis.Annals of intensive care · 2012Article
- Churg-Strauss syndrome following cessation of allergic desensitization vaccination: a case report.Journal of medical case reports · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The second part of this review addresses the treatment and prognosis of the vasculitides Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Treatment regimens consist of an initial remission phase with aggressive immunosuppression, followed by a more prolonged maintenance phase using less toxic agents and doses. This review focuses on the initial treatment of fulminant vasculitis, the mainstay of which remains immunosuppression with steroids and cyclophosphamide. For Wegener's granulomatosis and microscopic polyangiitis plasma exchange can be considered for first-line therapy in patients with acute renal failure and/or pulmonary haemorrhage. Refractory disease is rare and is usually due to inadequate treatment. The vasculitides provide a particular challenge for the critical care team. Particular aspects of major organ support related to these conditions are discussed. Effective treatment has revolutionized the prognosis of these conditions. However, mortality is still approximately 50% for those requiring admission to intensive care unit. Furthermore, there is a high morbidity associated with both the diseases themselves and the treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.